Definitive Healthcare Corp. (DH) Reports In-Line Q1 EPS, provides guidance

Definitive Healthcare Corp. (NASDAQ: DH) reported Q1 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $63.5 million versus the consensus estimate of $64.02 million.

GUIDANCE:

Definitive Healthcare Corp. sees Q2 2024 EPS of $0.08-$0.09, versus the consensus of $0.09. Definitive Healthcare Corp. sees Q2 2024 revenue of $62-63.5 million, versus the consensus of $65.151 million.

Full Year 2024:

Revenue is expected to be in the range of $255 – $261 million, versus the guidance of $266.3 million, a 1-4% increase from the prior year.

Adjusted Operating Income is expected to be in the range of $75.0 – $78.0 million.

Adjusted EBITDA is expected to be in the range of $81.5 – $84.5 million, for a full-year adjusted EBITDA margin of 32-33%.

Adjusted Net Income is expected to be $56.5 – $59.5 million.

Adjusted Net Income Per Diluted Share is expected to be $0.36 – $0.38, versus the consensus of $0.38 per share.

For earnings history and earnings-related data on Definitive Healthcare Corp. (DH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c